MARKET

BETRF

BETRF

Betterlife Pharma Inc
OTCMQB
0.180
0.000
0.00%
Closed 10:34 10/30 EDT
OPEN
0.180
PREV CLOSE
0.180
HIGH
0.180
LOW
0.180
VOLUME
3.00K
TURNOVER
540
52 WEEK HIGH
0.330
52 WEEK LOW
0.028
MARKET CAP
111.24M
P/E (TTM)
-11.5385
1D
5D
1M
3M
1Y
5Y
1D
BetterLife Pharma Taps LifeSci Advisors as It Advances BETR-001 Toward 2027 Clinical Milestones
TipRanks · 4d ago
BetterLife Pharma Appoints LifeSci Advisors as Investor Relations Firm
Newsfile · 4d ago
Weekly Report: what happened at BETRF last week (1019-1023)?
Weekly Report · 5d ago
BetterLife Pharma Strengthens Headache Program with New Scientific Advisory Co-Chair
TipRanks · 10/19 13:10
BetterLife Pharma Appoints Professor Richard B. Lipton as Co-Chair of its Scientific Advisory Board
Newsfile · 10/19 12:00
Weekly Report: what happened at BETRF last week (1012-1016)?
Weekly Report · 10/19 10:24
BetterLife Pharma Taps Clinical Veteran to Lead BETR-001 First-in-Human Study
TipRanks · 10/15 13:18
BetterLife Pharma Appoints Sheila Leitzinger as Head of Clinical Operations
Newsfile · 10/15 12:00
More
About BETRF
BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical, is a non-hallucinogenic second-generation lysergic acid diethylamide (LSD) derivative molecule that mimics the projected therapeutic potential of LSD in the treatment of disorders, such as depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders. BETR-002, which is in preclinical, is a formulation of a derivative of dihydrohonokiol, a known anti-anxiety compound, with the potential for treatment of anxiety related disorders, including benzodiazepine dependency. It is also refining and developing drug candidates from a set of complementary interferon-based technologies, which have the potential to engage the immune system to fight viral infections.

Webull offers BetterLife Pharma Inc stock information, including OTCMQB: BETRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BETRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BETRF stock methods without spending real money on the virtual paper trading platform.